Thank you to all participants for listening and engaging with us during the conference!

​

A big ‘Thank You’ goes to all speakers, who accepted our invitation to share their exciting research and are at the heart of the meeting. And to our sponsors for their dedication and financial support which allowed us to organize an outstanding program.

This year annual conference features disruptive innovations for personalized medicine through molecular engineering and molecular profiling of diseases. High-sensitive sensors, nano-devices and other technologies allow the continuous acquisition and analysis of individual health data, allowing detailed molecular examination and identification of biomarkers.

BioRN Annual conference showcases developments in precision technologies, their integration into clinical care and the upcoming challenges in data quality and patient data processing and storage.

Watch BioRN Annual Conference 2020 ON DEMAND

Molecular profiling of diseases

​

Vittoria Zinzalla, Head of Oncology Translational Science at Boehringer Ingelheim - Keynote

Johannes Betge, Junior Group Leader, Translational Gastrointestinal Oncology at University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University & German Cancer Research Center (DKFZ)

Rastislav Horos, Director Assay Development & Lab Services at Hummingbird Diagnostics GmbH

Nina Papavasiliou, Head of Division of Immune Diversity at German Cancer Research Center (DKFZ)

Engineering new sensors to probe biology

​

Kai Johnsson, Director at Max Planck Institute for Medical Research - Keynote

Benedikt Rauscher, Systems genetics and precision health - Postdoc Fellow at EMBL

Ulrich Rothbauer, Head of Dept. Pharma and Biotech at NMI Natural and Medical Sciences Institute at the University of Tübingen

Fireside Chat: Innovation potential in the BioRN Region

​

Siegfried Bialojan (BioRN & EY) discussed how optimally translate the existing potential in the region around Heidelberg into real innovation and value creation, with international guests: 
•  Johannes Frühauf, Founder and President, BioLabs and LabCentral
•  Thomas Hanke, Executive Vice President, Head of Academic Partnerships, Evotec SE
• Jürgen Bauer, Deputy Managing Director, EMBLEM Technology Transfer GmbH and Board Member, Heidelberg Startup partners
• Julia Schaft, Managing Director, BioRN Life Science Cluster Rhine-Neckar